Correct Answer: D. Antibiotic prophylaxis
Antibiotic prophylaxis is the standard of care for close contacts of meningococcal meningitis cases in the immediate post-exposure period. The discriminating principle is that prophylaxis prevents disease in exposed individuals who have not yet developed symptoms, whereas vaccination induces immunity over weeks—too slow for immediate protection. In India, as per IAP guidelines and RNTCP protocols, close contacts (classmates, family members) of confirmed meningococcal meningitis cases require chemoprophylaxis within 24 hours of diagnosis. The first-line agent is rifampicin (10 mg/kg/dose, twice daily for 2 days) or ceftriaxone (single IM dose of 125 mg for children <12 years, 250 mg for ≥12 years). Ciprofloxacin is an alternative in older children. This prophylaxis reduces the risk of secondary cases by ~90% and is mandatory for household contacts and school contacts in close proximity. The 12-year-old friend, being in the same class with two confirmed cases, qualifies as a close contact and requires immediate chemoprophylaxis, not vaccination. Vaccination is a long-term preventive strategy for the general population or high-risk groups, not an emergency measure for post-exposure contacts.
Why the other options are wrong
A. Single dose of meningococcal vaccine — Vaccination takes 7–14 days to generate protective antibody levels and is ineffective for immediate post-exposure prophylaxis. A single dose of meningococcal vaccine does not provide rapid protection to an already-exposed contact. Vaccines are for primary prevention in non-exposed populations, not post-exposure management. This is a common NBE trap—confusing vaccination strategy with post-exposure prophylaxis. B. Two doses of polysaccharide vaccine — Polysaccharide meningococcal vaccines (MPSV4) require 2–4 weeks for seroconversion and are not indicated for post-exposure contacts. The slow immune response makes them unsuitable for an already-exposed child. Additionally, polysaccharide vaccines have poor immunogenicity in children <2 years and waning immunity. They are used for routine immunization, not outbreak response. C. Two doses of conjugate vaccine — Conjugate meningococcal vaccines (MenACWY, MenB) are superior to polysaccharide vaccines but still require 1–2 weeks for protective immunity. Two doses spaced weeks apart are entirely inappropriate for a contact who is already exposed and at immediate risk. Conjugate vaccines are for primary prevention in routine schedules, not emergency post-exposure management.
High-Yield Facts
- Chemoprophylaxis (rifampicin or ceftriaxone) is the standard of care for close contacts of meningococcal meningitis within 24 hours of diagnosis.
- Rifampicin dose: 10 mg/kg twice daily for 2 days; ceftriaxone: single IM dose (125 mg <12 years, 250 mg ≥12 years).
- Vaccination (polysaccharide or conjugate) takes 7–14 days for seroconversion and is ineffective for post-exposure prophylaxis.
- Close contacts include household members, classmates in the same room, and healthcare workers with direct exposure—all require prophylaxis.
- Prophylaxis efficacy: ~90% reduction in secondary cases when given within 24 hours of diagnosis.
Mnemonics
POST-EXPOSURE: Prophylaxis, not Vaccination Prophylaxis (antibiotics) for POST-exposure contacts. Vaccination for Vulnerable populations (routine/high-risk). Post-exposure = antibiotics; routine prevention = vaccines. RIFAMPICIN RULE: 10-2-2 10 mg/kg, 2 times daily, for 2 days. Fastest chemoprophylaxis for meningococcal contacts in India.
NBE Trap
NBE pairs meningococcal disease with "vaccine" to lure students into choosing vaccination options. The trap is confusing primary prevention (vaccination) with post-exposure prophylaxis (antibiotics)—a critical distinction in outbreak management.
Clinical Pearl
In Indian schools, when meningococcal meningitis is confirmed in one or more students, the school health officer must immediately identify close contacts and initiate chemoprophylaxis within 24 hours—delaying for vaccination schedules risks secondary cases. This is a public health emergency requiring rapid antibiotic intervention, not immunization.
_Reference: IAP Guidelines on Meningococcal Disease Management; Harrison Ch. 173 (Meningococcal Infections); OP Ghai Pediatrics Ch. 10 (Infectious Diseases)_